We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 3,338

U.S. Antitrust Enforcers Weigh-In on Competitive Benefits of Telehealth
  • Arnold & Porter Kaye Scholer LLP
  • USA
  • December 7 2016

The top antitrust enforcers in the U.S. the Department of Justice Antitrust Division (“DOJ”) and the Federal Trade Commission (“FTC”) are tasked


Aetna and Humana Go to Battle With Regulators Over Multi-Billion Dollar Merger
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • December 5 2016

The trial over Aetna and Humana's $37 billion proposed merger kicked off today in a Washington, D.C. federal court. At issue is whether the


International News: Focus on International Dispute Resolution
  • McDermott Will & Emery
  • Chile, China, European Union, France, USA
  • December 1 2016

In October 2016, the European Commission launched a public consultation to


Look Before You Leap: Cautionary Tale of a Non-Reportable Transaction
  • McGuireWoods LLP
  • USA
  • November 29 2016

The list of non-reportable transactions challenged after the fact by the Department of Justice and the Federal Trade Commission continues to grow


New Antitrust Risks from Introducing New Drugs
  • Cooley LLP
  • USA
  • November 28 2016

Recent court decisions and statements by federal and state antitrust enforcers regarding “product hopping” - the practice of introducing a new version


Post-Election Analysis: Healthcare Antitrust in a Trump Administration
  • Manatt Phelps & Phillips LLP
  • USA
  • November 21 2016

In a Republican sweep of all the elected branches of the federal government, Donald Trump won the presidential election and Republicans retained


Teva Pharmaceuticals Sets Aside $520 Million for Potential FCPA Settlement
  • BuckleySandler LLP
  • USA
  • November 18 2016

Teva Pharmaceutical Industries Ltd. (Teva), an Israeli company, stated in its Form 6-K filed with the SEC on November 15, 2016, that it has set aside


Appeals Court Decisions Strengthen FTC's Hand in Hospital Merger Challenges
  • Holland & Knight LLP
  • USA
  • November 17 2016

U.S. Courts of Appeals for the Third and Seventh Circuits reversed district court denials of Federal Trade Commission (FTC) motions to


FTC Issues Compliance Guidance for Organizations that Share and Collect PHI
  • Baker & Hostetler LLP
  • USA
  • November 16 2016

The Federal Trade Commission (FTC) recently issued Guidance to remind HIPAA compliant organizations that share and collect protected health


The U.S. Legal and Regulatory Environment Under a Trump Administration
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • November 14 2016

Election Day brought an end to a long period of uncertainty that caused market fluctuations and delayed business planning decisions. As we navigate